Litigation

• Roche Loses Last Shot at Booting NJ Accutane Judge (subscription required)
• NuvaRing Lawsuits Remain on Hold, as Trial Date Cancelled
• Pfizer Faces Whistleblower Suit Over Lipitor Marketing (subscription required)
• Forest Can’t Nix Mo. Class In Antidepressant Marketing MDL (subscription required)
• Third Bellwether Trial in Bard Avaulta Mesh Litigation Delayed Indefinitely
• 8^th Circ. Affirms Novartis Loss in Aredia, Zometa Suit (subscription required)
• NJ High Court Stays Accutane Case, Weighs Judge’s Recusal (subscription required)

Regulatory

• FDA to Reopen Comment Period on the Cosmetics and Foods Portions of its Guidance on Determining if Human Research Studies Require an Investigational New Drug Application
• FDA Statement – Recommendation to Discontinue Prescribing and Dispensing 325 mg Acetaminophen Prescription
• Draft Guidance: Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media For Prescription Human and Animal Drugs and Biologics
• New Beverage Guidelines Say Some Supplement Additives Fall Under FDA
• Blood Glucose Meter Problems May Lead to New FDA Guidelines
• FDA Gives Drugmakers Taste of Social Media Rules (subscription required)
• FDA Pushes Hospitals to Buy from Registered Compounders (subscription required)

Recalls

• Liptruzet Recall Issued for All Lots of Combination Cholesterol Drug
• Tandem t:cell Insulin Cartridge Recall Issued Over Leaks
• Puritan Bennett 840 Series Ventilator I Recall – Software Problem

For a look at last week’s life science headlines, click here.